PDS Biotechnology Corporation (PDSB) vs Teladoc Health, Inc. (TDOC)
A side-by-side comparison of PDS Biotechnology Corporation and Teladoc Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 31, 2026. Differences are shown without an overall score or investment verdict.
PDSB
PDS Biotechnology Corporation
$0.21HealthcareDelayed quote: Aug 31, 2026, 4:00 PM EDT
TDOC
Teladoc Health, Inc.
$6.34HealthcareAt close: Aug 31, 2026, 4:00 PM ET
Total return — PDSB vs TDOC
growth of $100 · dividends reinvested · last 10yPDSB -99.9% (-49.0%/yr)TDOC -63.9% (-9.7%/yr)TDOC compounded faster over this window
Log scale — wide-divergence pair
PDSB TDOC
PDSB vs TDOC: by the numbers
- •TDOC is the larger company ($1.15B vs $12M market cap).
- •Both run net losses; PDSB's is the smaller (0.00% vs -7.13% net margin).
Metrics side by side
Valuation
| Metric | PDSB | TDOC |
|---|---|---|
| P/S ratio | N/A | 0.46 |
| P/B ratio | 3.45 | 0.87 |
| EV / EBITDA | 0.02 | 13.81 |
| FCF yield | N/A | 19.69% |
Profitability
| Metric | PDSB | TDOC |
|---|---|---|
| Gross margin | 0.00% | 73.53% |
| Operating margin | 0.00% | -6.98% |
| Net margin | 0.00% | -7.13% |
| ROE | -372.85% | -13.54% |
| ROIC | -3699.99% | -7.32% |
Growth (annualized)
| Metric | PDSB | TDOC |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 8.85% |
| FCF CAGR (5Y) | N/A | 25.56% |
| Total return CAGR (5Y) | -57.05% | -46.49% |
Frequently asked
- How have PDSB and TDOC total returns compared?
- Over the past 10 years, PDSB delivered -49.05% and TDOC delivered -9.82% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
PDS Biotechnology ROETeladoc Health ROEPDS Biotechnology operating marginTeladoc Health operating marginPDS Biotechnology revenue growthTeladoc Health revenue growthPDS Biotechnology free cash flowTeladoc Health free cash flow
PDS Biotechnology & Teladoc Health appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 31, 2026.